Cardiovascular hypertrophy and hypertension: causes and consequences

Area of Science:

• Cardiovascular Physiology
• Hypertension Research
• Vascular Biology

Background:

• Chronic hypertension is characterized by elevated vascular resistance and left ventricular (LV) hypertrophy, particularly in animal models.
• These changes contribute to enhanced hemodynamic performance, maintaining elevated blood pressure and microcirculatory exchange.
• Vascular remodeling, including luminal narrowing without increased medial mass, can result from non-uniform wall stress distribution.

Purpose of the Study:

• To explore the mechanisms underlying elevated blood pressure and structural changes in chronic hypertension.
• To investigate the roles of angiotensin II, sympathetic nervous system, and angiotensin-converting enzyme (ACE) in hypertension development.
• To assess the potential benefits of targeting cardiovascular hypertrophy regression in human hypertension therapy.

Main Methods:

• Analysis of hemodynamic changes and vascular remodeling in hypertensive models (e.g., Goldblatt hypertension, Spontaneously Hypertensive Rats - SHR).
• Investigation of the effects of interventions like neonatal sympathectomy, prazosin treatment, and ACE inhibitors.
• Examination of the impact of antihypertensive drugs on cardiovascular hypertrophy regression in human hypertension.

Main Results:

• Goldblatt hypertension involves renal artery stenosis resistance, angiotensin II (AngII) effects, and later, cardiovascular amplifier roles.
• Sympathetic nervous system activity is critical for BP elevation and structural changes in SHR; sympathectomy prevents these.
• ACE plays a similar role in cardiovascular development in SHR and WKY rats; ACE inhibitors attenuate hypertension long-term in SHR.

Conclusions:

• Therapeutic strategies aimed at regressing cardiovascular hypertrophy are valuable in managing human hypertension.
• Hypertrophy regression can mitigate non-uniform capillary blood flow distribution, reducing the risk of rarefaction and organ damage.
• Understanding the complex interplay of vascular resistance, hypertrophy, and neurohormonal factors is key to effective hypertension management.